During the inauguration of Danone OneBiome Laboratory in Paris-Saclay, Microbiomepost.com sat down with Emmanuel Perrin, Advanced Technology Ingredients Senior Director Danone, to explore Danone’s vision for harnessing the microbiome to guide the next generation of nutrition solutions. 

Emmanuel Perrin emphasizes how the composition of the gut microbiota is shaped early in life and influenced by multiple factors, including environment, medications, and especially diet. Food emerges as a primary interface with the microbiota, capable of maintaining diversity and resilience, thereby supporting long-term health. 

Leveraging the capabilities of Danone’s OneBiome laboratories, researchers can analyze human microbiome composition and identify how specific foods impact it positively or negatively, enabling the design of tailored dietary interventions. The discussion highlights precision fermentation as a transformative tool to produce bioactive compounds with targeted functions, and describes the company’s strain collection as a unique “innovation bank” that, through robotic screening, helps identify optimal conditions for health applications. 

Strategic collaborations and recent acquisitions, such as ventures into postbiotics, further expand the portfolio of microbiome-based solutions. Looking ahead, Danone envisions the evolution of microbiome science along three axes—personalized, predictive, and protective (the “3P” model)—to create food innovations that anticipate individual needs and contribute to healthier lives.